Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMR Vaccine Excretion in Breast Milk of Breastfeeding Women (BREMEAVAC)
NCT02325310Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2015
- Primary completion
- May 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of measles, mumps and rubella vaccine (live) in measles, mumps and rubella, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Prevalence of the measles vaccine virus strain in breast milk at 14 days. Started Feb 2015; status: completed.
02
Drugs
measles, mumps and rubella vaccine (live)
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT02325310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02325310.